Paper39723966
Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice.
Hammoud R and 12 others. JCI Insight, 2024. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice. Papers, record 39723966. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39723966
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Gastrointestinal Hormone | Major topic |
| Gastric Inhibitory Polypeptide | Major topic |
| Inflammation | Major topic |
| Animals | |
| Mice | |
| Signal Transduction | |
| Fluorouracil | |
| Glucagon-Like Peptide-1 Receptor | |
| Glucagon-Like Peptide 1 | |
| Male | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Disease Models, Animal |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33320179 | Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. | Endocr Rev | 2021 | https://conductscience.org/library/papers/33320179 | PubMed |
| 2 | 31447324 | Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake. | Cell Metab | 2019 | https://conductscience.org/library/papers/31447324 | PubMed |
| 3 | 36027914 | Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation. | Cell Metab | 2022 | https://conductscience.org/library/papers/36027914 | PubMed |
| 4 | 8462365 | Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8462365 | PubMed |
| 5 | 26442437 | Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium. | Annu Rev Physiol | 2016 | https://conductscience.org/library/papers/26442437 | PubMed |
| 6 | 12724731 | 5-fluorouracil: mechanisms of action and clinical strategies. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12724731 | PubMed |
| 7 | 36509857 | Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/36509857 | PubMed |
| 8 | 17498508 | Biology of incretins: GLP-1 and GIP. | Gastroenterology | 2007 | https://conductscience.org/library/papers/17498508 | PubMed |
| 9 | 34380697 | GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models. | Diabetes | 2021 | https://conductscience.org/library/papers/34380697 | PubMed |
| 10 | 32849649 | Dietary Glucose Consumption Promotes RALDH Activity in Small Intestinal CD103+CD11b+ Dendritic Cells. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849649 | PubMed |
| 11 | 7022018 | The "Swiss roll": a simple technique for histological studies of the rodent intestine. | Lab Anim | 1981 | https://conductscience.org/library/papers/7022018 | PubMed |
| 12 | 25217161 | Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation. | J Immunol | 2014 | https://conductscience.org/library/papers/25217161 | PubMed |
| 13 | 37366315 | Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37366315 | PubMed |
| 14 | 24161075 | Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. | Annu Rev Physiol | 2014 | https://conductscience.org/library/papers/24161075 | PubMed |
| 15 | 21095180 | The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice. | Biochem Biophys Res Commun | 2011 | https://conductscience.org/library/papers/21095180 | PubMed |
| 16 | 29444223 | GLP-1 Receptor Expression Within the Human Heart. | Endocrinology | 2018 | https://conductscience.org/library/papers/29444223 | PubMed |
| 17 | 32389828 | The gut hormone receptor GIPR links energy availability to the control of hematopoiesis. | Mol Metab | 2020 | https://conductscience.org/library/papers/32389828 | PubMed |
| 18 | 32542357 | Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. | Blood | 2020 | https://conductscience.org/library/papers/32542357 | PubMed |
| 19 | 32084389 | Distinct Mesenchymal Cell Populations Generate the Essential Intestinal BMP Signaling Gradient. | Cell Stem Cell | 2020 | https://conductscience.org/library/papers/32084389 | PubMed |
| 20 | 25735732 | GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R. | Diabetes | 2015 | https://conductscience.org/library/papers/25735732 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783450 | The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia? | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783450 | PubMed |
| 42525756 | Altered Gi signaling in enteroendocrine K cells in vivo causes pronounced changes in glucose homeostasis. | Sci Adv | 2026 | https://conductscience.org/library/papers/42525756 | PubMed |
| 42421032 | Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease. | J Transl Med | 2026 | https://conductscience.org/library/papers/42421032 | PubMed |
| 41904760 | Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated proatherogenic effects in macrophages: evidence for M1/M2 homeostasis restoration. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/41904760 | PubMed |
| 41419097 | Loss of GLP-2R signaling in Glp2r-/- mice increases the long-term severity of graft versus host disease. | Mol Metab | 2026 | https://conductscience.org/library/papers/41419097 | PubMed |
| 41345787 | Intestinal adaptation to cold-induced metabolic demand and feeding requires GLP-1R and GLP-2R signalling. | Commun Biol | 2025 | https://conductscience.org/library/papers/41345787 | PubMed |
| 41208029 | Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications. | Protein Cell | 2026 | https://conductscience.org/library/papers/41208029 | PubMed |
| 41178710 | Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits. | J Clin Invest | 2025 | https://conductscience.org/library/papers/41178710 | PubMed |
| 41082103 | The role of the incretin GIP in inflammation. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/41082103 | PubMed |
| 40972535 | Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential. | J Crohns Colitis | 2025 | https://conductscience.org/library/papers/40972535 | PubMed |
| 40843763 | Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/40843763 | PubMed |
| 40723884 | Gut Hormones and Inflammatory Bowel Disease. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723884 | PubMed |
| 40590228 | Therapeutic horizons in metabolic dysfunction-associated steatohepatitis. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40590228 | PubMed |
| 40566497 | Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40566497 | PubMed |
| 40521880 | Therapeutic Targeting of the GIP Receptor-Revisiting the Controversies. | Diabetes | 2025 | https://conductscience.org/library/papers/40521880 | PubMed |
| 40437450 | Association between oral microbial diversity (only bacteria) and diabetes in U.S. adults: analysis of NHANES 2009-2012 data. | BMC Oral Health | 2025 | https://conductscience.org/library/papers/40437450 | PubMed |
| 40004833 | Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004833 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GIPR | 2696 | PubTator's text mining | https://conductscience.org/library/genes/2696 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39723966
GET https://conductscience.org/api/papers/v1/39723966/references?page=2